Filing Details

Accession Number:
0001209191-20-049796
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-09-08 20:01:09
Reporting Period:
2020-09-08
Accepted Time:
2020-09-08 20:01:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1566044 Vyne Therapeutics Inc. VYNE Pharmaceutical Preparations (2834) 453757789
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1616284 Andrew Saik 520 U.s. Highway 22, Suite 204
Bridgewater NJ 08807
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-09-08 40,000 $1.46 340,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. These shares were purchased in multiple transactions at prices ranging from $1.4499 to $1.4767 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.